Brief: Virpax Pharmaceuticals Inc Signs Agreement With Sinclair Research To Initiate Investigational New Drug (IND)-Enabling Studies For Anqlar
Oct 6 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS INC SIGNS AGREEMENT WITH SINCLAIR
RESEARCH TO INITIATE INVESTIGATIONAL NEW DRUG (IND)-ENABLING
STUDIES FOR ANQLAR
* VIRPAX PHARMACEUTICALS INC - STUDIES ARE EXPECTED TO BEGIN
IN
JANUARY OF 2022
Source text for Eikon: ID:nBw4PVSxla
Further company coverage: VRPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study